Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancers|January 11, 2024
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and FunctionsQuaovi H Sodji, Matthew H Forsberg, Dan Cappabianca, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccinationPeter M Carlson, Ravi B Patel, Jen Birstler, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|July 4, 2021
First-in-human imaging using a MR-compatible e4D ultrasound probe for motion management of radiotherapyBryan P Bednarz, Sydney Jupitz, Warren Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Radiation Research|April 7, 2021
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the BrainPaul A Clark, Raghava N Sriramaneni, Amber M Bates, et al.
Theranostics|May 17, 2021
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapyJustin C Jagodinsky, Won Jong Jin, Amber M Bates, et al.
Radiation Research|March 25, 2026
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcsCaroline P Kerr, Won Jong Jin, Alejandro J Oñate, et al.
Nature Communications|January 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in miceCaroline P Kerr, Won Jong Jin, Peng Liu, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibitionCaroline P Kerr, Won Jong Jin, Peng Liu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.
Pageof 6